RadMit, Inc.

We develop novel drugs that induce DNA repair and prevent cancer

Raising $10,000,000
(

You can request access to view the full terms of this fundraise.

Request Access

Quick Pitch

RadMit, Inc develops novel radiation mitigators and anticancer drugs which reduce genetic instability and DNA damage induced by a whole variety of DNA damaging agents and carcinogens such as ionizing radiation, UV, EMS, MMS, nitrogen mustard, radioactive iodine and cigarette smoke extract. Use indludes as stockpile for governments against radiation accidents or terrorist actions, in radiation oncology, as biological sunscreen, antidote against chemical warfare, against spontaneous cancer, against cigarette smoke induced cancer, against radon induced cancer, for astronauts and pilots and flight attendants that have a higher cancer risk due to space radiation, against genetic instability and DNA repair deficient diseases.

Product/Service Details

RadMit, Inc. in Encino, California, is a research company that produces new chemicals that induce DNA repair for use as radiation mitigators, cancer chemoprevention, biological sunscreen, anti-aging, anti-pollution, cosmetics, and other purposes. To make this possible, we isolate novel chemicals with a high-throughput screen against radiation-induced DNA deletions and toxicity screening through 16,000 chemicals.

Traction & Accomplishments

When mice are irradiated with a lethal dose where usually 100% of them die and the first dose of our radiation mitigator is given 24 hours after the radiation, we can rescue 100%. Radition induced leukemia is from 90% reduced to 40% and the spontaneous frequency from 10% down to 0%. Weekly injection of the compound increases the life expectancy of Atm deficient mice of which usually 90% die from lymphoma for 16 weeks which is about 12 years in human life expectancy. We want to develop this chemical first as a treament of Ataxia Telangiectasia of which Atm deficient mice is a model. This is an orphan disease and FDA approval for this is much faster than for regular drugs. In the menatime we will contiue with other applications as listed above.

How We're Different

Other radiation mitigators prevent toxicity of radiation and thus micht actually increase the cancer risk. Our mitigators are selected in the first place also against radiaiton induced genetic instability. Compounds that induce DNA repair are completely unique.

Team

Robert H. Schiestl - Owner

 


See above


Klaus Bernhardt - CEO

 


He was 15 years in upper management position with Pfizer.


Alex Wallstein - Director of Business Development

 


He had several positions for business development with Danaher and major drug companies.


The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.


Request Access

N

No updates yet.




%

No backers yet.




Quick Signup TBD

You must have an account to do this!


the startups.com platform

Copyright © 2019 Startups.com. All rights reserved.

Fundable is a software as a service funding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.